Advocacy intelligence hub — real-time data for patient organizations
Blueprint Medicines Corporation
Universitaire Ziekenhuizen KU Leuven — PHASE4
University of Thessaly
Lille Catholic University
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Browse all Autosomal recessive spastic paraplegia type 21 news →
View all Autosomal recessive spastic paraplegia type 21 specialists →